These results demonstrated the presence of the immunosuppressive KIR2DL5/PVR pathway within the TME of various human cancers of bladder, kidney, breast, lung, liver, cerebrum, prostate, colon, esophagus, pancreas, uterus, and stomach, which tumors may exploit as an immune evasion mechanism. This evidence concerns the gene PVR and cancer.